$CNAT Earnings Call (Q4 2014)

0
523
Biotech Stocks

Conatus Pharmaceuticals Inc Earnings Call (Q4 2014)

Conatus Pharmaceuticals Inc Earnings Call (Q4 2014)
Wed, Mar 11, 2015, 4:30 pm Eastern

Listen to the archived event audio
About Conatus Pharmaceuticals Inc (NasdaqGM:CNAT) Other Calls
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active pan-caspase protease inhibitor for the treatment of acute-on-chronic liver failure; chronic liver failure; post liver transplant clearance of hepatitis C virus infection with sustained viral response; non-alcoholic steatohepatitis; and nonalcoholic fatty liver disease. The company was founded in 2005 and is headquartered in San Diego, California.

LEAVE A REPLY

Please enter your comment!
Please enter your name here